Medical specialists from Canada tagged as investigators in clinical trials studying Neoplasms, Second Primary
Total 38 results
-
Abhenil Mittal, MDSeen in:
- Ontario, Sudbury, Health Sciences North
Trials:- NCT04151342 (Principal Investigator)
-
Amit OzaSeen in:
- Ontario, Toronto, Princess Margaret
- Ontario, Toronto, Princess Margaret Cancer Centre - University Health Network
- Ontario, Toronto, Princess Margaret Hospital
- Ontario, Toronto, University Health Network - Princess Margaret Hospital
- Ontario, Toronto, University health Network (UHN)-University of Toronto
Trials:- NCT05483933 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05041257 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Peritoneal Cancer;
- Endometrial Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Ayesha Bashir, MD, FRCPCSeen in:
- Saskatchewan, Regina, Allan Blair Cancer Centre
Trials:- NCT04151342 (Principal Investigator)
-
Cheryl Ho, MD, FRCPCSeen in:
- British Columbia, Vancouver, BC Cancer
Trials:- NCT04151342 (Principal Investigator)
-
Denis Soulières, MDSeen in:
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal
Trials:- NCT04989725 (Sub-Investigator)
Conditions: -
Derek JonkerSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
- Ontario, Ottawa, Ottawa Hospital Cancer Centre (OHRI)
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Diane ProvencherSeen in:
- Quebec, Montréal, CHUM - University of Montreal Hospital Centre
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, Centre hospitalier de l'Universite de Montreal (CHUM)
Trials:- NCT05456685 (Principal Investigator)
- NCT04260802 (Principal Investigator)
- NCT05329545 (Principal Investigator)
- NCT02632448 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- High Grade Serous Ovarian Cancer;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Elizabeth Faour, MDSeen in:
- Newfoundland and Labrador, Saint John's, Dr. H. Bliss Murphy Cancer Centre
Trials:- NCT04151342 (Principal Investigator)
-
Geoffrey Liu, MD, MScSeen in:
- Ontario, Toronto, Princess Margaret Cancer Centre (PMCC) - University Health Network (UHN)
Trials:- NCT04151342 (Principal Investigator)
-
Houda Bahig, MD, PhDSeen in:
- Quebec, Montréal, Centre Hospitalier de l'Universite de Montreal
- Quebec, Montréal, Centre Hospitalier de l'Université de Montréal-CHUM
Trials:- NCT04989725 (Principal Investigator)
- NCT05717166 (Principal Investigator)
Conditions: -
Ines Menjak, MD, FRCPCSeen in:
- Ontario, Toronto, Sunnybrook Research Institute - Sunnybrook Health Sciences Centre
Trials:- NCT04151342 (Principal Investigator)
-
Jason Agulnik, MDSeen in:
- Quebec, Montreal, Jewish General Hospital
- Quebec, Montréal, Jewish General Hospital
Trials:- NCT04564079 (Principal Investigator)
- NCT04151342 (Principal Investigator)
-
Jonathan Spicer, MD, PhDSeen in:
- Quebec, Montréal, McGill University Health Centre
Trials:- NCT04151342 (Principal Investigator)
-
Juan F Asenjo, MDSeen in:
- Quebec, Montreal, Montreal General Hospital
Trials:- NCT00294073 (Principal Investigator)
- NCT00294151 (Principal Investigator)
Conditions: -
Karen Zhang, PHDSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT06101849 (Principal Investigator)
Conditions: -
Kevin Jao, MD, PhDSeen in:
- Quebec, Montréal, Hôpital du Sacré-Coeur-de-Montréal (HSCM)
Trials:- NCT04151342 (Principal Investigator)
-
Luisa Galvis-Gomez, MDSeen in:
- New Brunswick, Fredericton, Dr. Everett Chalmers Regional Hospital
Trials:- NCT04151342 (Principal Investigator)
-
Michel PavicSeen in:
- Quebec, Sherbrooke, Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hopital Fleurimont
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
- Quebec, Sherbrooke, Centre hospitalier universitaire de Sherbrooke (CHUS)
- Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke CHUS
Trials:- NCT04879329 (Principal Investigator)
- NCT05590377 (Principal Investigator)
- NCT02488967 (Principal Investigator)
- NCT05220098 (Principal Investigator)
Conditions:- Urothelial Carcinoma;
- Multiple Myeloma;
- Stage IIIA Breast Cancer;
- Stage IB Breast Cancer;
- Stage IIA Breast Cancer;
- Stage IIB Breast Cancer;
- Stage IIIC Breast Cancer;
- Estrogen Receptor Negative;
- HER2/Neu Negative;
- Progesterone Receptor Negative;
- Triple-Negative Breast Carcinoma;
- Breast Adenocarcinoma;
- Unresectable Locally Advanced or Metastatic Cancer
-
Nicholas Meti, MDSeen in:
- Quebec, Montréal, CIUSSS Ouest de l'ile de Montreal - St-Mary's Hospital
- Quebec, Montréal, St. Mary's Hospital
- Quebec, Montréal, St. Mary's Hospital Center
Trials:- NCT04541212 (Principal Investigator)
- NCT04151342 (Principal Investigator)
-
Nicolas Marcoux, MD, FRCPCSeen in:
- Quebec, Québec City, Centre hospitalier de l'université de Québec - Université Laval
Trials:- NCT04151342 (Principal Investigator)
-
Nicole Bouchard, MDSeen in:
- Quebec, Sherbrooke, Centre hospitalier universitaire de Sherbrooke (CHUS)
Trials:- NCT04564079 (Principal Investigator)
- NCT04151342 (Principal Investigator)
-
Normand Blais, MD, MScSeen in:
- Quebec, Montréal, Centre hospitalier de l'Universite de Montreal (CHUM)
Trials:- NCT04151342 (Principal Investigator)
-
Olexiy Aseyev, MDSeen in:
- Ontario, Thunder Bay, Thunder Bay Regional Health Sciences Centre
Trials:- NCT04151342 (Principal Investigator)
-
Oliver DumarSeen in:
- Quebec, Centre intégré de cancérologie du CHU de Québec - Université Laval
Trials:- NCT05220098 (Principal Investigator)
-
Parneet Cheema, MD, FRCPCSeen in:
- Ontario, Brampton, William Osler Health System - Brampton Civic Hospital
Trials:- NCT04151342 (Principal Investigator)
-
Paul Wheatley-Price, MBChB, FRCP(UK), MDSeen in:
- Ontario, Ottawa, Ottawa Hospital Cancer Centre
Trials:- NCT04151342 (Principal Investigator)
-
Philippe Joubert, MD, PhDSeen in:
- Quebec, Québec City, Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Trials:- NCT04151342 (Principal Investigator)
-
Quincy ChuSeen in:
- Alberta, Edmonton, Cross Cancer Institute
- Alberta, Edmonton, GSK Investigational Site
Trials:- NCT04260802 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT03739710 (Principal Investigator)
- NCT06077877 (Principal Investigator)
Conditions:- Sarcoma;
- Neoplasms;
- Renal Cell Carcinoma;
- Cervical Cancer;
- Cancer;
- Hepatocellular Carcinoma;
- Gastric Cancer;
- Ovarian Cancer;
- Non Small Cell Lung Cancer;
- Metastatic Cancer;
- Squamous Cell Carcinoma of Head and Neck;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Urothelial Carcinoma;
- Merkel Cell Carcinoma;
- Squamous Cell Carcinoma;
- Locally Advanced Malignant Neoplasm;
- Locally Advanced Solid Tumor;
- Urothelial Neoplasm;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Rectal Cancer;
- Endometrial Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer
-
Quincy Siu-Chung Chu, MD, FRCPCSeen in:
- Alberta, Edmonton, Cross Cancer Institute, University of Alberta - Alberta Health Services
Trials:- NCT04151342 (Principal Investigator)
-
Ronald Burkes, MD, FRCPCSeen in:
- Ontario, Toronto, Mount Sinai Hospital
Trials:- NCT04151342 (Principal Investigator)
Clinical Trials on Neoplasms, Second Primary
-
Centre Leon BerardCompleted
-
Centre Leon BerardGlaxoSmithKlineRecruitingRecurrent Cancer | Second Cancer | Primary CancerFrance
-
Lawson Health Research InstituteCompletedHIV Infections | Cancer, Second PrimaryCanada
-
BayerCompletedProstatic NeoplasmsGermany
-
Ludwig-Maximilians - University of MunichMerck KGaA, Darmstadt, Germany; ClinAssess GmbHActive, not recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Recruiting
-
Centre Hospitalier de PerigueuxUniversity Hospital, LimogesRecruitingTherapy-Associated CancerFrance
-
Ludwig-Maximilians - University of MunichAmgen; ClinAssess GmbHNot yet recruitingTreatment Related CancerGermany
-
Shenzhen Fifth People's HospitalUnknown
-
Kantonsspital GraubuendenKlinik Hirslanden, ZurichCompletedNeoplasms, Second PrimarySwitzerland